CVS HEALTH CORP's ticker is CVS and the CUSIP is 126650100. A total of 1,507 filers reported holding CVS HEALTH CORP in Q3 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.9%.
About CVS HEALTH CORP
CVS Health Corp is a leading healthcare company that operates in the United States. The company provides a wide range of healthcare services, including pharmacy services, health insurance, and retail clinics. CVS Health Corp has been in the news recently due to its acquisition of Aetna, a major health insurance provider. This acquisition has positioned CVS Health Corp as a major player in the healthcare industry.
The acquisition of Aetna has allowed CVS Health Corp to expand its reach and offer a more comprehensive range of healthcare services to its customers. The company now has the ability to offer health insurance, pharmacy services, and retail clinics all under one roof. This integration of services is expected to improve the overall healthcare experience for customers and reduce costs.
CVS Health Corp has also been investing heavily in technology to improve its services. The company has launched a mobile app that allows customers to manage their prescriptions, schedule appointments, and access health information. This app has been well-received by customers and has helped to improve the overall customer experience.
In conclusion, CVS Health Corp is a leading healthcare company that is well-positioned for growth. The company's acquisition of Aetna and investment in technology are expected to drive growth and improve the overall healthcare experience for customers. Investors should keep an eye on CVS Health Corp as it continues to expand its reach and offer innovative healthcare solutions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $4,119,080 | -28.7% | 69,744 | -3.7% | 0.08% | -29.7% |
| Q1 2024 | $5,775,580 | +37.6% | 72,412 | +36.3% | 0.11% | +46.1% |
| Q4 2023 | $4,196,013 | +35.9% | 53,141 | +20.2% | 0.08% | +26.7% |
| Q3 2023 | $3,087,091 | -16.3% | 44,215 | -17.2% | 0.06% | -11.8% |
| Q2 2023 | $3,689,675 | +2.5% | 53,373 | +10.2% | 0.07% | -5.6% |
| Q1 2023 | $3,599,575 | +97449.5% | 48,440 | +22.3% | 0.07% | -35.7% |
| Q4 2022 | $3,690 | -99.9% | 39,602 | -8.7% | 0.11% | -17.6% |
| Q3 2022 | $4,135,000 | +46.0% | 43,355 | +41.8% | 0.14% | +36.0% |
| Q2 2022 | $2,833,000 | -6.8% | 30,582 | +1.8% | 0.10% | -15.3% |
| Q1 2022 | $3,039,000 | -4.8% | 30,033 | -2.9% | 0.12% | -5.6% |
| Q4 2021 | $3,192,000 | +12.3% | 30,941 | -7.6% | 0.12% | -8.1% |
| Q3 2021 | $2,842,000 | +1.9% | 33,488 | +0.1% | 0.14% | +3.0% |
| Q2 2021 | $2,790,000 | +6.6% | 33,442 | -3.9% | 0.13% | +7.3% |
| Q1 2021 | $2,617,000 | +12.4% | 34,782 | +2.1% | 0.12% | +3.4% |
| Q4 2020 | $2,328,000 | +24.0% | 34,073 | +5.9% | 0.12% | -9.8% |
| Q3 2020 | $1,878,000 | -16.4% | 32,169 | -7.0% | 0.13% | -29.8% |
| Q2 2020 | $2,247,000 | +13.1% | 34,582 | +3.2% | 0.19% | -21.7% |
| Q1 2020 | $1,987,000 | -55.3% | 33,497 | -48.3% | 0.24% | +0.8% |
| Q4 2019 | $4,448,000 | +117.2% | 64,787 | +99.4% | 0.24% | -3.6% |
| Q3 2019 | $2,048,000 | +28.8% | 32,484 | +11.3% | 0.25% | +42.8% |
| Q2 2019 | $1,590,000 | -58.2% | 29,178 | -58.7% | 0.17% | -59.2% |
| Q1 2019 | $3,808,000 | -1.0% | 70,605 | +20.3% | 0.42% | -9.4% |
| Q4 2018 | $3,846,000 | +64.9% | 58,694 | +98.2% | 0.47% | +80.7% |
| Q3 2018 | $2,332,000 | +13.2% | 29,616 | -7.5% | 0.26% | +2.4% |
| Q2 2018 | $2,060,000 | -0.7% | 32,007 | -4.0% | 0.25% | -10.3% |
| Q1 2018 | $2,074,000 | -4.4% | 33,331 | +11.4% | 0.28% | -3.4% |
| Q4 2017 | $2,170,000 | -61.6% | 29,921 | -57.0% | 0.29% | -60.3% |
| Q3 2017 | $5,653,000 | +1.9% | 69,519 | +0.8% | 0.74% | +3.2% |
| Q2 2017 | $5,550,000 | -7.2% | 68,979 | -9.5% | 0.71% | -1.7% |
| Q1 2017 | $5,981,000 | +20.6% | 76,186 | +21.2% | 0.72% | +33.5% |
| Q4 2016 | $4,958,000 | -33.7% | 62,835 | -25.2% | 0.54% | -20.3% |
| Q3 2016 | $7,477,000 | -13.2% | 84,018 | -6.7% | 0.68% | -11.8% |
| Q2 2016 | $8,617,000 | -15.7% | 90,004 | -8.7% | 0.77% | -9.6% |
| Q1 2016 | $10,227,000 | +28.7% | 98,586 | +21.3% | 0.85% | +47.2% |
| Q4 2015 | $7,948,000 | -74.6% | 81,294 | -74.9% | 0.58% | -50.1% |
| Q3 2015 | $31,278,000 | +73.0% | 324,186 | +88.1% | 1.16% | -7.2% |
| Q2 2015 | $18,076,000 | +8.7% | 172,354 | +6.9% | 1.25% | +8.8% |
| Q1 2015 | $16,636,000 | +6.5% | 161,180 | -0.6% | 1.15% | -3.9% |
| Q4 2014 | $15,619,000 | +21.6% | 162,171 | +0.5% | 1.20% | +13.8% |
| Q3 2014 | $12,847,000 | +24.1% | 161,412 | +17.5% | 1.05% | +19.4% |
| Q2 2014 | $10,351,000 | -13.3% | 137,336 | -13.8% | 0.88% | -18.3% |
| Q1 2014 | $11,932,000 | +5.6% | 159,386 | +0.9% | 1.08% | +5.1% |
| Q4 2013 | $11,303,000 | -25.9% | 157,929 | -41.3% | 1.03% | +76.2% |
| Q3 2013 | $15,256,000 | +3.2% | 268,835 | +3.9% | 0.58% | -4.0% |
| Q2 2013 | $14,789,000 | – | 258,637 | – | 0.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| St. James Investment Company, LLC | 870,302 | $70,024,000 | 8.65% |
| CORTLAND ASSOCIATES INC/MO | 522,022 | $42,002,000 | 8.06% |
| Veritas Investment Management LLP | 660,923 | $53,194,000 | 7.77% |
| CLARK ESTATES INC/NY | 530,702 | $42,700,000 | 7.34% |
| Ashburton (Jersey) Ltd | 145,534 | $11,710,000 | 6.66% |
| Focused Investors LLC | 1,712,300 | $137,772,000 | 5.85% |
| Veritas Investment Management (UK) Ltd | 185,104 | $14,893,000 | 5.72% |
| International Value Advisers | 2,274,189 | $182,981,000 | 5.65% |
| Vulcan Value Partners, LLC | 7,689,383 | $618,688,000 | 5.51% |
| Veritas Asset Management LLP | 8,438,564 | $678,967,000 | 5.30% |